{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:52:57Z","timestamp":1782129177564,"version":"3.54.5"},"reference-count":36,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: In recent years, frailty has emerged as a prognostic factor in inflammatory bowel diseases (IBD), particularly among patients with active disease. However, evidence regarding its reversibility after treatment optimization remains limited. This study aimed to assess frailty in active IBD and determine whether frailty status improved after 6 months of clinical management and the achievement of clinical remission. Materials and Methods: This prospective, single-center, observational cohort study included adults with active IBD requiring escalation to advanced therapy who achieved clinical remission at the 6-month follow-up. Patients were evaluated at baseline and after 6 months using a modified Fried frailty phenotype. Quality of life was assessed using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ), and depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. Univariate and multivariate logistic regressions were utilized to identify independent factors associated with frailty improvement. Results: The analysis included 54 patients (61.1% male; 42.6% with Crohn\u2019s disease). At baseline, 20.4% were classified as frail, 72.2% as pre-frail, and 7.4% as robust. Following 6 months of clinical management and the achievement of clinical remission, a 100% resolution of frailty was observed, with the robust cohort expanding to 42.6%. Significant improvements occurred across clinical parameters, including handgrip strength, 400 m walk times, and median SIBDQ scores (increasing from 4.4 to 5.9, p &lt; 0.001) alongside a substantial decline in CES-D scores (p = 0.017). Multivariate logistic regression revealed that severe disease at baseline (aOR = 4.51, 95%CI: 1.26\u201316.18, p = 0.020), anti-TNF therapy initiation (aOR = 3.69, 95%CI: 1.04\u201313.18, p = 0.044), and higher baseline CES-D scores (aOR = 1.06, 95%CI: 1.00\u20131.13, p = 0.038) were independently associated with higher odds of frailty improvement. Conclusions: Among patients who achieved clinical remission, frailty and pre-frailty demonstrate substantial short-term improvement following advanced therapy. Functional and psychological recoveries are associated with successful control of baseline disease severity and systemic inflammation.<\/jats:p>","DOI":"10.3390\/medicina62061192","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:49:55Z","timestamp":1782121795000},"page":"1192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reversal of Frailty and Improvement in Quality of Life Following Advanced Therapy Initiation in Patients with Inflammatory Bowel Disease: A Prospective Cohort Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4965-0702","authenticated-orcid":false,"given":"Mihaela","family":"Topala","sequence":"first","affiliation":[{"name":"Doctoral School, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Infection Control Unit, Bucharest Clinical Emergency Hospital, 014461 Bucharest, Romania"},{"name":"Center for Excellence in Translational Medicine, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cojocaru","sequence":"additional","affiliation":[{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"},{"name":"Discipline of Gastroenterology and Hepatology, Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8545-310X","authenticated-orcid":false,"given":"Razvan","family":"Iacob","sequence":"additional","affiliation":[{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"},{"name":"Discipline of Gastroenterology and Hepatology, Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana Simona","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"},{"name":"Discipline of Gastroenterology and Hepatology, Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Vadan","sequence":"additional","affiliation":[{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, 022328 Bucharest, Romania"},{"name":"Discipline of Gastroenterology and Hepatology, Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2025). Prioritizing inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol., 22, 361.","DOI":"10.1038\/s41575-025-01078-4"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.dld.2023.06.009","article-title":"Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis","volume":"56","author":"Barberio","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jab\u0142o\u0144ska, B., and Mrowiec, S. (2023). Nutritional Status and Its Detection in Patients with Inflammatory Bowel Diseases. Nutrients, 15.","DOI":"10.3390\/nu15081991"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ncp.10628","article-title":"Nutrition Considerations in Inflammatory Bowel Disease","volume":"36","author":"Lin","year":"2021","journal-title":"Nutr. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","article-title":"Depression and anxiety in inflammatory bowel disease: Epidemiology, mechanisms and treatment","volume":"19","author":"Bisgaard","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in Older Adults: Evidence for a Phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.32157","article-title":"Frailty is associated with increased risk of cirrhosis disease progression and death","volume":"75","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2476740","DOI":"10.1080\/0886022X.2025.2476740","article-title":"Chronic kidney disease overall survival prediction model based on frailty index score: Construction and validation using NHANES data","volume":"47","author":"Li","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s11739-023-03405-6","article-title":"Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis","volume":"18","author":"Verduri","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ageing\/afy110","article-title":"The prevalence of frailty and its association with clinical outcomes in general surgery: A systematic review and meta-analysis","volume":"47","author":"Hewitt","year":"2018","journal-title":"Age Ageing"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurjpc\/zwaa167","article-title":"Frailty in cardiology: Definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and","volume":"29","author":"Richter","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.18390","article-title":"Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Diseases","volume":"61","author":"Carbery","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10620-021-06990-8","article-title":"Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty","volume":"67","author":"Kochar","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Salvatori, S., Marafini, I., Franchin, M., Lavigna, D., Brigida, M., Venuto, C., Biancone, L., Calabrese, E., Giannarelli, D., and Monteleone, G. (2023). Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072658"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis","volume":"317","author":"Schroeder","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_18","first-page":"69","article-title":"Grip and pinch strength: Normative data for adults","volume":"66","author":"Mathiowetz","year":"1985","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_20","unstructured":"MacDermid, J., and Solomon, G.V.K. (2015). Clinical Assessment Recommendations, American Society of Hand Therapists. [3rd ed.]."},{"key":"ref_21","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s10620-025-09073-0","article-title":"Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease","volume":"70","author":"Bahirwani","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ibd\/izac242","article-title":"Frail Phenotype in Patients With Inflammatory Bowel Disease","volume":"29","author":"Salvatori","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"otaf010","DOI":"10.1093\/crocol\/otaf010","article-title":"Investigation and Analysis of Frailty and Nutritional Status in Patients With Inflammatory Bowel Disease","volume":"7","author":"Liu","year":"2025","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000528459","article-title":"The Prevalence and Factors That Impact Frailty in Inflammatory Bowel Disease Patients Hospitalized in a Tertiary Hospital in China","volume":"41","author":"You","year":"2023","journal-title":"Dig. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","article-title":"Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management","volume":"23","author":"Dent","year":"2019","journal-title":"J. Nutr. Health Aging"},{"key":"ref_28","first-page":"263","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on IBD in the Elderly","volume":"11","author":"Sturm","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.gastro.2020.08.060","article-title":"AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review","volume":"160","author":"Ananthakrishnan","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3399\/bjgp18X700241","article-title":"Delaying and reversing frailty: A systematic review of primary care interventions","volume":"69","author":"Travers","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ibd\/izy015","article-title":"Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses\u2014Part II","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/jcsm.13341","article-title":"Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study","volume":"14","author":"Zhang","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e70206","DOI":"10.1002\/jcsm.70206","article-title":"Physical Activity Improves Quality of Life in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"17","author":"Csendes","year":"2026","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1016\/j.cgh.2021.06.015","article-title":"Deficits in Geriatric Assessment Associate with Disease Activity and Burden in Older Patients with Inflammatory Bowel Disease","volume":"20","author":"Asscher","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ecco-jcc\/jjad175","article-title":"Frailty Screening is Associated with Hospitalization and Decline in Quality of Life and Functional Status in Older Patients with Inflammatory Bowel Disease","volume":"18","author":"Asscher","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.2147\/JIR.S551065","article-title":"Development of a Prediction Model for Combined Assessment of SII, Albumin, and Fibrinogen to Evaluate Frailty Risk in Patients with Inflammatory Bowel Disease","volume":"18","author":"Li","year":"2025","journal-title":"J. Inflamm. Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:34:45Z","timestamp":1782128085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061192"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061192","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}